Stock Rich List
#744 on the corporate holders of 809 holders

SR One Capital Partners I, LP

10% owner at Design Therapeutics.

$60.8M
in disclosed stock, −$979K (−1.58%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
744th of 809
Companies held
1
Largest holding
DSGN, 100.0% of total
Latest SEC filing
Dec 20, 2022

What the $60.8M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Design Therapeutics DSGN
Common Stock
Directly6,526,476$9.32$60.8M100.0%Form 4, Dec 20, 2022

Share counts are the amounts SR One Capital Partners I, LP reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
741Dimension Capital II, L.P.
Director, Odyssey Therapeutics
$61.1M−$2.1M (−3.37%)
742E.J. Elliott, LLC
10% owner, Gencor Industries
$61.1M−$956K (−1.54%)
743American Tower Corp /ma/
Insider, AST SpaceMobile
$60.9M+$143K (+0.24%)
744SR One Capital Partners I, LP
10% owner, Design Therapeutics
$60.8M−$979K (−1.58%)
745Drive Capital Overdrive Fund I (te), L.P.
10% owner, Root
$60.6M−$2.6M (−4.09%)
746Drive Capital Overdrive Ignition Fund I, L.P.
10% owner, Root
$60.6M−$2.6M (−4.09%)
747Dragsa 96 LLC
10% owner, Amylyx Pharmaceuticals
$60.3M−$966K (−1.58%)

Other Design Therapeutics insiders

All DSGN insiders

Questions

How much stock does SR One Capital Partners I, LP own?

SR One Capital Partners I, LP holds $60,826,756 in listed stock based on SEC filings and current prices, mostly Design Therapeutics (DSGN). That ranks 744th on the Stock Rich List.

Is this SR One Capital Partners I, LP's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.